Compare CCB & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCB | IART |
|---|---|---|
| Founded | 1997 | 1989 |
| Country | United States | United States |
| Employees | N/A | 4427 |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2018 | 1996 |
| Metric | CCB | IART |
|---|---|---|
| Price | $70.04 | $15.11 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 7 |
| Target Price | ★ $126.67 | $14.33 |
| AVG Volume (30 Days) | 149.6K | ★ 1.1M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $96.61 | $4.39 |
| Revenue Next Year | $22.66 | $3.40 |
| P/E Ratio | $89.97 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $66.50 | $8.70 |
| 52 Week High | $120.05 | $16.42 |
| Indicator | CCB | IART |
|---|---|---|
| Relative Strength Index (RSI) | 38.40 | 70.06 |
| Support Level | $66.50 | $12.64 |
| Resistance Level | $118.72 | $16.35 |
| Average True Range (ATR) | 2.17 | 0.91 |
| MACD | -0.10 | 0.11 |
| Stochastic Oscillator | 35.42 | 90.11 |
Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.